NEW YORK – June 16, 2025 – The Cardiovascular Research Foundation® (CRF®) announced the lineup of Late-Breaking Clinical Trials to be presented at New York Valves: The Structural Heart Summit taking place June 25-27, 2025, at the Jacob K. Javits Convention Center, North in New York, NY.
This year’s program will spotlight 12 late-breaking trials, showcasing the latest advances, key trial results, and innovative therapies transforming the field of structural heart disease. Formerly known as the Transcatheter Valve Therapy (TVT®) conference and now in its second year, New York Valves 2025 continues to evolve as the must-attend educational meeting for interventionalists, imagers, surgeons, and the entire heart team.
The late-breaking clinical research that will be presented at New York Valves will unveil the latest advances in transcatheter aortic valve replacement, alongside innovations in mitral and tricuspid devices and techniques. Data from these trials will help guide the selection of patients who will benefit most from these procedures and help define optimal treatment strategies, tools, and techniques for new and emerging treatments.
Wednesday, June 25, 2025
Late-Breaking Clinical Trials 1: Aortic
10:30 AM — 11:30 AM EDT
Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial
Allan Schwartz
Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial
Sammy Elmariah
TAVR Reintervention Strategies: Unveiling Trends and Outcomes of Redo TAVR and TAVR Explant
Shinichi Fukuhara
Early US Commercial Experience With a Self-Expandable Transcatheter Aortic Valve With Intra-Annular Leaflet Position
Santiago Garcia
Thursday, June 26, 2025
Late Breaking Clinical Trials 2: Tricuspid
10:30 AM — 11:30 AM EDT
Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER
Matthew J. Price
TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement
Paul A. Grayburn
Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study
Suzanne V. Arnold
Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries
Julio Echarte Morales
Friday, June 27, 2025
Late Breaking Clinical Trials 3: Mitral
10:30 AM — 11:30 AM EDT
Two-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study
Gilbert H. L. Tang
Clinical and Quality-of-Life Outcomes With the PASCAL System in Early Commercial Experience From the STS/ACC TVT Registry
Santiago Garcia
Global and Regional Burden of Non-Rheumatic Degenerative Mitral Valve Disease: Implications for Transcatheter Therapies
Guido Ascione
One Year Results of a Clinical Study Using a Novel Polymeric Valve for Surgical Mitral Valve Replacement
Isaac George
A world-class educational experience, New York Valves features three days of transformative research and techniques that redefine the landscape of structural heart interventions. This dynamic meeting brings together interventional cardiologists, cardiac surgeons, clinical cardiologists, cardiac imagers, heart failure specialists, and other members of the heart team in the spirit of multidisciplinary collaboration. Attendees will have the unique opportunity to leverage the collective expertise of diverse specialties to create innovative and personalized treatment strategies for patients with valvular and structural heart disease.
In addition to the 12 late-breaking trials, New York Valves will feature:
- 20+ live cases showcasing groundbreaking procedures performed by world-renowned operators from 17 prestigious medical institutions
- 14 featured clinical science presentations
- 150+ moderated abstracts
- 180+ challenging cases
- New this year! The LAAC Summit, a one-day, high-impact program featuring real-world case reviews and live cases with critical insights from leading experts.
- And much more!
HOW TO REGISTER:
Media may apply for press registration by emailing jromero@crf.org.
About CRF®
The Cardiovascular Research Foundation® (CRF®) is a global leader in interventional cardiovascular medicine, driving innovation, spearheading groundbreaking research, and transforming education in the field. Through its relentless pursuit of excellence, CRF® not only accelerates medical breakthroughs but also equips healthcare professionals with the tools and knowledge necessary to enhance survival rates and elevate the quality of life for millions worldwide. CRF®’s centers of excellence include the CRF® Skirball Center for Innovation, CRF® Clinical Trials Center, CRF® Center for Education, CRF® Digital, TCTMD®, and Structural Heart: The Journal of the Heart Team.
###